The “Nutrigenomics Market, 2022-2035” report features an extensive study of the current market landscape and future potential of nutrigenomics focused companies over the next decade.

Key Inclusions

 A detailed overview of the overall landscape of the companies offering nutrigenomics tests, along with information on several relevant parameters, such as their year of establishment, company size (in terms of employee count), location of headquarters (North America, Europe, Asia-Pacific and Middle East and North Africa) and type of business model (business-to-consumer (B2C) and business-to-business (B2C)). The chapter also covers details related to the type of genetic test offered (nutritional deficiency, food intolerance / sensitivity, nutrient metabolism, disease risk assessment and others), associated services offered (diet customization, lifestyle management, weight management and others, type of sample analyzed (buccal swab, saliva, blood and others), type of sample collection method (at-home sample collection and lab sample collection) and target therapeutic area (cardiovascular disorders, metabolic disorders, neurological disorders, immunological disorders, dermatological disorders, musculoskeletal disorders, gastrointestinal disorders, oncological disorders, ophthalmic disorders, respiratory disorders, infectious diseases, hematological disorders and others).